Nesiritide fails to reduce the mortality of patients with acute decompensated heart failure: An updated systematic review and cumulative meta-analysis
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference21 articles.
1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
2. Effect of nesiritide in patients with acute decompensated heart failure;O'Connor;N Engl J Med,2011
3. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial;Yancy;Circ Heart Fail,2008
4. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure;Chow;J Card Fail,2011
5. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure;Silver;J Am Coll Cardiol,2002
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Autoregulation: mediators and renin–angiotensin system in diseases and treatments;Future Journal of Pharmaceutical Sciences;2023-04-07
2. Nesiritide in patients with acute myocardial infarction and heart failure: a meta-analysis;Journal of International Medical Research;2020-01
3. Specialty-Related Differences in the Acute-Phase Treatment and Prognosis in Patients With Acute Heart Failure ― Insights From REALITY-AHF ―;Circulation Journal;2018-12-25
4. Randomized double-blind clinical studies of ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta-analysis;ESC Heart Failure;2018-09-24
5. Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials;European Journal of Clinical Pharmacology;2016-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3